Evolus, Inc. Common Stock (EOLS) is a publicly traded Healthcare sector company. As of October 21, 2026, EOLS trades at $7.31 with a market cap of $486.13M and a P/E ratio of -14.42. EOLS moved -0.68% today. Year to date, EOLS is +9.67%; over the trailing twelve months it is +10.16%. Its 52-week range spans $3.86 to $14.94. Analyst consensus is strong buy with an average price target of $14.33. Rallies surfaces EOLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest EOLS news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $7.31 |
| Market Cap | $486.13M |
| P/E Ratio | -14.42 |
| EPS | $-0.52 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.94 |
| 52-Week Low | $3.86 |
| Volume | 54.42K |
| Avg Volume | 0 |
| Revenue (TTM) | $316.49M |
| Net Income | $-34.33M |
| Gross Margin | 66.73% |
5 analysts cover EOLS: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $14.33.